Ikena Oncology Inc. (IKNA): Is this the Most Sought-After Stock Today? – Invest Chronicle
Home  »  Stock   »  Ikena Oncology Inc. (IKNA): Is this the Most Sough...

Ikena Oncology Inc. (IKNA): Is this the Most Sought-After Stock Today?

Let’s start up with the current stock price of Ikena Oncology Inc. (IKNA), which is $3.61 to be very precise. The Stock rose vividly during the last session to $3.93 after opening rate of $3.63 while the lowest price it went was recorded $3.41 before closing at $3.47.Recently in News on June 22, 2022, Ikena Oncology Receives FDA Fast Track Designation for Novel TEAD Inhibitor IK-930 to Treat Unresectable NF2-Deficient Mesothelioma. Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for IK-930, the Company’s novel TEAD inhibitor targeting the Hippo signaling pathway, in patients with unresectable NF2-deficient malignant pleural mesothelioma (MPM). You can read further details here

Ikena Oncology Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $14.35 on 01/04/22, with the lowest value was $2.83 for the same time period, recorded on 05/02/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Ikena Oncology Inc. (IKNA) full year performance was -75.39%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ikena Oncology Inc. shares are logging -79.47% during the 52-week period from high price, and 27.69% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.83 and $17.60.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2136233 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Ikena Oncology Inc. (IKNA) recorded performance in the market was -72.33%, having the revenues showcasing -52.40% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 117.84M, as it employees total of 67 workers.

The Analysts eye on Ikena Oncology Inc. (IKNA)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.00, with a change in the price was noted -5.69. In a similar fashion, Ikena Oncology Inc. posted a movement of -60.79% for the period of last 100 days, recording 179,873 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for IKNA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of Ikena Oncology Inc. (IKNA)

Raw Stochastic average of Ikena Oncology Inc. in the period of last 50 days is set at 16.53%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 29.85%. In the last 20 days, the company’s Stochastic %K was 25.54% and its Stochastic %D was recorded 24.43%.

Considering, the past performance of Ikena Oncology Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -72.33%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -73.91%, alongside a downfall of -75.39% for the period of the last 12 months. The shares increased approximately by -13.03% in the 7-day charts and went down by -6.22% in the period of the last 30 days. Common stock shares were lifted by -52.40% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts